Screener
Bristol-Myers Squibb BMY Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
Plus components not separately reported this period.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's total debt?
- Bristol-Myers Squibb (BMY) reported total debt of $43.33B in Q2 2026.
- How has Bristol-Myers Squibb's total debt changed year-over-year?
- Bristol-Myers Squibb's total debt decreased by 12.3% year-over-year, from $49.38B to $43.33B.
- What is the long-term trend for Bristol-Myers Squibb's total debt?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total debt has grown at a -1.9% compound annual growth rate (CAGR), from $51.85B to $47.14B.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Bristol-Myers Squibb's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude